GPS Tracker for Hepatitis C

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen ByCamilo Zaks, MD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Southern California

No Placebo Group

Trial Summary

What is the purpose of this trial?The goal of this study is to determine if GPS tracking can enhance adherence to hepatitis C treatment among patients diagnosed with hepatitis C infection who are also experiencing unsheltered homelessness and receiving street medicine. Research will compare medication adherence among participants randomly assigned to receive standard medical care for Hepatitis C versus the standard medical care for Hepatitis C along with GPS tracking assistance.

Eligibility Criteria

This trial is for individuals with hepatitis C who are experiencing homelessness and receiving street medicine. It aims to see if using a GPS tracker can help them stick to their treatment plan.

Inclusion Criteria

I have been diagnosed with Hepatitis C.

I meet the criteria for simplified Hep C treatment.

Exclusion Criteria

I have had a liver transplant.

I have tested positive for hepatitis B.

I have or might have liver cancer.

My liver is severely damaged and cannot function properly.

Participant Groups

The study is testing whether a GPS tracking device improves medication adherence in patients getting standard care for Hepatitis C, by comparing two groups: one with just the care and another adding the GPS assistance.

2Treatment groups

Active Control

Group I: Standard HCV treatmentActive Control1 Intervention

Participants randomized to this study arm will receive the standard medical care for Hepatitis C.

Group II: Standard HCV treatment + GPS tracker deviceActive Control1 Intervention

Participants randomized to this study arm will receive the standard medical care for Hepatitis C and a GPS tracker device.